SCHEMBL1820437

SCHEMBL1820437

COc1cc(C#N)[c]cn1

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.36
LOX P28300 1/20 0.31
LOXL2 Q9Y4K0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL958642 0.71
SCHEMBL1886864 0.71 LOX (0.34) LOXLOXL2
SCHEMBL4922129 0.69
SCHEMBL907706 0.69
SCHEMBL4927705 0.69
SCHEMBL4885716 0.67 LOX (0.32) LOXLOXL2
SCHEMBL3003551 0.65 CA2 (0.34) LOXLOXL2
SCHEMBL4882790 0.64 LOX (0.30) LOXLOXL2
SCHEMBL4405141 0.64 HPGDS (0.41) RECQLLOXLOXL2
SCHEMBL1097322 0.64 KDM4E (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 WO disclosed